Rare variants in SQSTM1 and VCP genes and risk of sporadic inclusion body myositis

Neurobiology of Aging

Volumn 47, Issue , 2016, Pages 218.e1-218.e9

  Gang, Qiang ^a,o   Bettencourt, Conceicao ^o   Machado, Pedro M ^a,b,o   Brady, Stefen ^a,c,o   Holton, Janice L ^a,o   Pittman, Alan M ^a,d   Hughes, Deborah ^a   Healy, Estelle ^a,o   Parton, Matthew ^a,o   Hilton Jones, David ^c,o   Shieh, Perry B ^e,o   Needham, Merrilee ^f,o   Liang, Christina ^g,o   Zanoteli, Edmar ^h,o   de Camargo, Leonardo Valente ^h,o   De Paepe, Boel ^i,o   De Bleecker, Jan ^i,o   Shaibani, Aziz ^j,o   Ripolone, Michela ^k,o   Violano, Raffaella ^k,o   Moggio, Maurizio ^k,o   Barohn, Richard J ^l,o   Dimachkie, Mazen M ^l,o   Mora, Marina ^m,o   Mantegazza, Renato ^m,o   Zanotti, Simona ^m,o   Singleton, Andrew B ⁿ   Hanna, Michael G ^a,o   Houlden, Henry ^a,o   McVey, April L ^o   Pasnoor, Mamatha ^o   Glenn, Melanie ^o   Jawdat, Omar ^o   Statland, Jeffrey ^o   Rico, Gabrielle ^o   Mastaglia, Frank ^o   Dalakas, Marinos C ^o   Biba, Angie ^o   Chinoy, Hector ^o   Lilleker, James B ^o   Lamb, Janine ^o   Platt, Hazel ^o   Cooper, Robert G ^o   Miller, James A L ^o   Roberts, Mark ^o   Househam, Elizabeth ^o   Hilton, David ^o   Shivane, Aditya ^o   Bartlett, Amy ^o   Kissel, John T ^o   Runk, Heidi ^o   Wicklund, Matthew ^o   Saperstein, David S ^o   McKinney, Lynette R ^o   more..

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^g ROYAL NORTH SHORE HOSPITAL   (Australia)

^h UNIVERSITY OF SÃO PAULO   (Brazil)

ⁱ GHENT UNIVERSITY HOSPITAL   (Belgium)

^j Nerve and Muscle Center of Texas   (United States)

^k UNIVERSITY OF MILAN   (Italy)

^l UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

^m DEPARTMENT OF NEUROSURGERY   (Italy)

ⁿ NATIONAL INSTITUTES OF HEALTH   (United States)

^o NONE

more..

Author keywords

Genetic risk factor; sIBM; Sporadic inclusion body myositis; SQSTM1; VCP

Indexed keywords

CD74 ANTIGEN; HLA A ANTIGEN; HLA DR ANTIGEN; MESSENGER RNA; SEQUESTOSOME 1; VALOSIN CONTAINING PROTEIN; ADENOSINE TRIPHOSPHATASE; CDC48 PROTEIN; CELL CYCLE PROTEIN; SQSTM1 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; CD74 GENE; CONTROLLED STUDY; FEMALE; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HETEROZYGOSITY; HLA A GENE; HLA DRA GENE; HUMAN; HUMAN TISSUE; INCLUSION BODY MYOSITIS; MAJOR CLINICAL STUDY; MALE; MISSENSE MUTATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUESTOSOME 1 GENE; TRANSCRIPTOMICS; UPREGULATION; VALOSIN CONTAINING PROTEIN GENE; WHOLE EXOME SEQUENCING; GENETIC ASSOCIATION STUDY; GENETIC PREDISPOSITION; GENETIC VARIATION; GENETICS; MIDDLE AGED; RISK; VERY ELDERLY;

ADENOSINE TRIPHOSPHATASES; AGED; AGED, 80 AND OVER; CELL CYCLE PROTEINS; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; HUMANS; MIDDLE AGED; MYOSITIS, INCLUSION BODY; RISK; SEQUESTOSOME-1 PROTEIN;

EID: 84994512347     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2016.07.024     Document Type: Article

References (45)

1. Abramzon, Y., Johnson, J.O., Scholz, S.W., Taylor, J.P., Brunetti, M., Calvo, A., Mandrioli, J., Benatar, M., Mora, G., Restagno, G., Chio, A., Traynor, B.J., Valosin-containing protein (VCP) mutations in sporadic amyotrophic lateral sclerosis. Neurobiol. Aging 33 (2012), 2231.e1–2231.e6.
2. Adzhubei, I.A., Schmidt, S., Peshkin, L., Ramensky, V.E., Gerasimova, A., Bork, P., Kondrashov, A.S., Sunyaev, S.R., A method and server for predicting damaging missense mutations. Nat. Methods 7 (2010), 248–249.
3. Badrising, U.A., Maat-Schieman, M., van Duinen, S.G., Breedveld, F., van Doorn, P., van Engelen, B., van den Hoogen, F., Hoogendijk, J., Howeler, C., de Jager, A., Jennekens, F., Koehler, P., van der Leeuw, H., de Visser, M., Verschuuren, J.J., Wintzen, A.R., Epidemiology of inclusion body myositis in The Netherlands: a nationwide study. Neurology 55 (2000), 1385–1387.
4. Bersano, A., Del Bo, R., Lamperti, C., Ghezzi, S., Fagiolari, G., Fortunato, F., Ballabio, E., Moggio, M., Candelise, L., Galimberti, D., Virgilio, R., Lanfranconi, S., Torrente, Y., Carpo, M., Bresolin, N., Comi, G.P., Corti, S., Inclusion body myopathy and frontotemporal dementia caused by a novel VCP mutation. Neurobiol. Aging 30 (2009), 752–758.
5. Brady, S., Squier, W., Sewry, C., Hanna, M., Hilton-Jones, D., Holton, J.L., A retrospective cohort study identifying the principal pathological features useful in the diagnosis of inclusion body myositis. BMJ Open, 4, 2014, e004552.
6. Bucelli, R.C., Arhzaouy, K., Pestronk, A., Pittman, S.K., Rojas, L., Sue, C.M., Evila, A., Hackman, P., Udd, B., Harms, M.B., Weihl, C.C., SQSTM1 splice site mutation in distal myopathy with rimmed vacuoles. Neurology 85 (2015), 665–674.
7. Chan, N., Le, C., Shieh, P., Mozaffar, T., Khare, M., Bronstein, J., Kimonis, V., Valosin-containing protein mutation and Parkinson's disease. Parkinsonism Relat. Disord. 18 (2012), 107–109.
8. Cuyvers, E., van der Zee, J., Bettens, K., Engelborghs, S., Vandenbulcke, M., Robberecht, C., Dillen, L., Merlin, C., Geerts, N., Graff, C., Thonberg, H., Chiang, H.H., Pastor, P., Ortega-Cubero, S., Pastor, M.A., Diehl-Schmid, J., Alexopoulos, P., Benussi, L., Ghidoni, R., Binetti, G., Nacmias, B., Sorbi, S., Sanchez-Valle, R., Llado, A., Gelpi, E., Almeida, M.R., Santana, I., Clarimon, J., Lleo, A., Fortea, J., de Mendonca, A., Martins, M., Borroni, B., Padovani, A., Matej, R., Rohan, Z., Ruiz, A., Frisoni, G.B., Fabrizi, G.M., Vandenberghe, R., De Deyn, P.P., Van Broeckhoven, C., Sleegers, K., Genetic variability in SQSTM1 and risk of early-onset Alzheimer dementia: a European early-onset dementia consortium study. Neurobiol. Aging 36 (2015), 2005.e15–2005.e22.
9. Dabby, R., Lange, D.J., Trojaborg, W., Hays, A.P., Lovelace, R.E., Brannagan, T.H., Rowland, L.P., Inclusion body myositis mimicking motor neuron disease. Arch. Neurol. 58 (2001), 1253–1256.
10. Daroszewska, A., van 't Hof, R.J., Rojas, J.A., Layfield, R., Landao-Basonga, E., Rose, L., Rose, K., Ralston, S.H., A point mutation in the ubiquitin-associated domain of SQSMT1 is sufficient to cause a Paget's disease-like disorder in mice. Hum. Mol. Genet. 20 (2011), 2734–2744.
11. Davydov, E.V., Goode, D.L., Sirota, M., Cooper, G.M., Sidow, A., Batzoglou, S., Identifying a high fraction of the human genome to be under selective constraint using GERP++. PLoS Comput. Biol., 6, 2010, e1001025.
12. Fecto, F., Yan, J., Vemula, S.P., Liu, E., Yang, Y., Chen, W., Zheng, J.G., Shi, Y., Siddique, N., Arrat, H., Donkervoort, S., Ajroud-Driss, S., Sufit, R.L., Heller, S.L., Deng, H.X., Siddique, T., SQSTM1 mutations in familial and sporadic amyotrophic lateral sclerosis. Arch. Neurol. 68 (2011), 1440–1446.
13. Gang, Q., Bettencourt, C., Machado, P., Hanna, M.G., Houlden, H., Sporadic inclusion body myositis: the genetic contributions to the pathogenesis. Orphanet J. Rare Dis., 9, 2014, 88.
14. Gang, Q., Bettencourt, C., Machado, P.M., Fox, Z., Brady, S., Healy, E., Parton, M., Holton, J.L., Hilton-Jones, D., Shieh, P.B., Zanoteli, E., De Paepe, B., De Bleecker, J., Shaibani, A., Ripolone, M., Violano, R., Moggio, M., Barohn, R.J., Dimachkie, M.M., Mora, M., Mantegazza, R., Zanotti, S., Hanna, M.G., Houlden, H., The effects of an intronic polymorphism in TOMM40 and APOE genotypes in sporadic inclusion body myositis. Neurobiol. Aging 36 (2015), 1766.e1–1766.e3.
15. Gidaro, T., Modoni, A., Sabatelli, M., Tasca, G., Broccolini, A., Mirabella, M., An Italian family with inclusion-body myopathy and frontotemporal dementia due to mutation in the VCP gene. Muscle Nerve 37 (2008), 111–114.
16. Griggs, R.C., Askanas, V., DiMauro, S., Engel, A., Karpati, G., Mendell, J.R., Rowland, L.P., Inclusion body myositis and myopathies. Ann. Neurol. 38 (1995), 705–713.
17. Haubenberger, D., Bittner, R.E., Rauch-Shorny, S., Zimprich, F., Mannhalter, C., Wagner, L., Mineva, I., Vass, K., Auff, E., Zimprich, A., Inclusion body myopathy and Paget disease is linked to a novel mutation in the VCP gene. Neurology 65 (2005), 1304–1305.
18. Hilton-Jones, D., Miller, A., Parton, M., Holton, J., Sewry, C., Hanna, M.G., Inclusion body myositis: MRC Centre for Neuromuscular diseases, IBM workshop, London, 13 June 2008. Neuromuscul. Disord. 20 (2010), 142–147.
19. Ivanidze, J., Hoffmann, R., Lochmuller, H., Engel, A.G., Hohlfeld, R., Dornmair, K., Inclusion body myositis: laser microdissection reveals differential up-regulation of IFN-gamma signaling cascade in attacked versus nonattacked myofibers. Am. J. Pathol. 179 (2011), 1347–1359.
20. Johnson, J.O., Mandrioli, J., Benatar, M., Abramzon, Y., Van Deerlin, V.M., Trojanowski, J.Q., Gibbs, J.R., Brunetti, M., Gronka, S., Wuu, J., Ding, J., McCluskey, L., Martinez-Lage, M., Falcone, D., Hernandez, D.G., Arepalli, S., Chong, S., Schymick, J.C., Rothstein, J., Landi, F., Wang, Y.D., Calvo, A., Mora, G., Sabatelli, M., Monsurro, M.R., Battistini, S., Salvi, F., Spataro, R., Sola, P., Borghero, G., Galassi, G., Scholz, S.W., Taylor, J.P., Restagno, G., Chio, A., Traynor, B.J., Exome sequencing reveals VCP mutations as a cause of familial ALS. Neuron 68 (2010), 857–864.
21. Ju, J.S., Fuentealba, R.A., Miller, S.E., Jackson, E., Piwnica-Worms, D., Baloh, R.H., Weihl, C.C., Valosin-containing protein (VCP) is required for autophagy and is disrupted in VCP disease. J. Cell. Biol. 187 (2009), 875–888.
22. Komatsu, M., Kageyama, S., Ichimura, Y., p62/SQSTM1/A170: physiology and pathology. Pharmacol. Res. 66 (2012), 457–462.
23. Koppers, M., van Blitterswijk, M.M., Vlam, L., Rowicka, P.A., van Vught, P.W.J., Groen, E.J.N., Spliet, W.G.M., Engelen-Lee, J., Schelhaas, H.J., de Visser, M., van der Kooi, A.J., van der Pol, W.L., Pasterkamp, R.J., Veldink, J.H., van den Berg, L.H., VCP mutations in familial and sporadic amyotrophic lateral sclerosis. Neurobiol. Aging 33 (2012), 837.e7–837.e13.
24. Kumar, P., Henikoff, S., Ng, P.C., Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat. Protoc 4 (2009), 1073–1081.
25. Kwok, C.T., Morris, A., de Belleroche, J.S., Sequestosome-1 (SQSTM1) sequence variants in ALS cases in the UK: prevalence and coexistence of SQSTM1 mutations in ALS kindred with PDB. Eur. J. Hum. Genet. 22 (2014), 492–496.
26. Laurin, N., Brown, J.P., Morissette, J., Raymond, V., Recurrent mutation of the gene encoding sequestosome 1 (SQSTM1/p62) in Paget disease of bone. Am. J. Hum. Genet. 70 (2002), 1582–1588.
27. Le Ber, I., Camuzat, A., Guerreiro, R., Bouya-Ahmed, K., Bras, J., Nicolas, G., Gabelle, A., Didic, M., De Septenville, A., Millecamps, S., Lenglet, T., Latouche, M., Kabashi, E., Campion, D., Hannequin, D., Hardy, J., Brice, A., SQSTM1 mutations in French patients with frontotemporal dementia or frontotemporal dementia with amyotrophic lateral sclerosis. JAMA Neurol. 70 (2013), 1403–1410.
28. Lotz, B.P., Engel, A.G., Nishino, H., Stevens, J.C., Litchy, W.J., Inclusion body myositis. Observations in 40 patients. Brain 112 (1989), 727–747.
29. Machado, P.M., Dimachkie, M.M., Barohn, R.J., Sporadic inclusion body myositis: new insights and potential therapy. Curr. Opin. Neurol. 27 (2014), 591–598.
30. Majounie, E., Traynor, B.J., Chio, A., Restagno, G., Mandrioli, J., Benatar, M., Taylor, J.P., Singleton, A.B., Mutational analysis of the VCP gene in Parkinson's disease. Neurobiol. Aging 33 (2012), 209.e1–209.e2.
31. Mencacci, N.E., Rubio-Agusti, I., Zdebik, A., Asmus, F., Ludtmann, M.H., Ryten, M., Plagnol, V., Hauser, A.K., Bandres-Ciga, S., Bettencourt, C., Forabosco, P., Hughes, D., Soutar, M.M., Peall, K., Morris, H.R., Trabzuni, D., Tekman, M., Stanescu, H.C., Kleta, R., Carecchio, M., Zorzi, G., Nardocci, N., Garavaglia, B., Lohmann, E., Weissbach, A., Klein, C., Hardy, J., Pittman, A.M., Foltynie, T., Abramov, A.Y., Gasser, T., Bhatia, K.P., Wood, N.W., A missense mutation in KCTD17 causes autosomal dominant myoclonus-dystonia. Am. J. Hum. Genet. 96 (2015), 938–947.
32. Meyer, H., Weihl, C.C., The VCP/p97 system at a glance: connecting cellular function to disease pathogenesis. J. Cell. Sci. 127 (2014), 3877–3883.
33. Miller, L., Rollinson, S., Callister, J.B., Young, K., Harris, J., Gerhard, A., Neary, D., Richardson, A., Snowden, J., Mann, D.M.A., Pickering-Brown, S.M., p62/SQSTM1 analysis in frontotemporal lobar degeneration. Neurobiol. Aging 36 (2015), 1603.e5–1603.e9.
34. Ralston, S.H., Layfield, R., Pathogenesis of Paget disease of bone. Calcified Tissue Int. 91 (2012), 97–113.
35. Ritchie, M.E., Phipson, B., Wu, D., Hu, Y., Law, C.W., Shi, W., Smyth, G.K., Limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res., 43, 2015, e47.
36. Rohrer, J.D., Warren, J.D., Reiman, D., Uphill, J., Beck, J., Collinge, J., Rossor, M.N., Isaacs, A.M., Mead, S., A novel exon 2 I27V VCP variant is associated with dissimilar clinical syndromes. J. Neurol. 258 (2011), 1494–1496.
37. Rubino, E., Rainero, I., Chio, A., Rogaeva, E., Galimberti, D., Fenoglio, P., Grinberg, Y., Isaia, G., Calvo, A., Gentile, S., Bruni, A.C., St George-Hyslop, P.H., Scarpini, E., Gallone, S., Pinessi, L., SQSTM1 mutations in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Neurology 79 (2012), 1556–1562.
38. Sandri, M., Autophagy in skeletal muscle. FEBS Lett. 584 (2010), 1411–1416.
39. Scheetz, T.E., Roos, B.R., Solivan-Timpe, F., Miller, K., DeLuca, A.P., Stone, E.M., Kwon, Y.H., Alward, W.L.M., Wang, K., Fingert, J.H., SQSTM1 mutations and glaucoma. PLoS One, 11, 2016, e0156001.
40. Schmittgen, T.D., Livak, K.J., Analyzing real-time PCR data by the comparative C(T) method. Nat. Protoc. 3 (2008), 1101–1108.
41. Schwarz, J.M., Cooper, D.N., Schuelke, M., Seelow, D., MutationTaster2: mutation prediction for the deep-sequencing age. Nat. Methods 11 (2014), 361–362.
42. Tawil, R., Griggs, R.C., Inclusion body myositis. Curr. Opin. Rheumatol. 14 (2002), 653–657.
43. Trabzuni, D., Ryten, M., Walker, R., Smith, C., Imran, S., Ramasamy, A., Weale, M.E., Hardy, J., Quality control parameters on a large dataset of regionally dissected human control brains for whole genome expression studies. J. Neurochem. 119 (2011), 275–282.
44. Watts, G.D., Wymer, J., Kovach, M.J., Mehta, S.G., Mumm, S., Darvish, D., Pestronk, A., Whyte, M.P., Kimonis, V.E., Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein. Nat. Genet. 36 (2004), 377–381.
45. Weihl, C.C., Baloh, R.H., Lee, Y., Chou, T.F., Pittman, S.K., Lopate, G., Allred, P., Jockel-Balsarotti, J., Pestronk, A., Harms, M.B., Targeted sequencing and identification of genetic variants in sporadic inclusion body myositis. Neuromuscul Disord. 25 (2015), 289–296.